| Trial ID: | L0110 |
| Source ID: | NCT01248650
|
| Associated Drug: |
Nalfurafine Hydrochloride
|
| Title: |
Safety Study of TRK-820 for Patient With Hemodialysis
|
| Acronym: |
TRK-820
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Renal Failure
|
| Interventions: |
DRUG: nalfurafine hydrochloride
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: SK Chemicals Co., Ltd. | Collaborators: Toray Industries, Inc
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
16
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-12
|
| Completion Date: |
2008-12
|
| Results First Posted: |
|
| Last Update Posted: |
2010-11-25
|
| Locations: |
Samsung Medical Center, Seoul, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT01248650
|
